Systemic chemotherapy for advanced non-small cell lung cancer: recent advances and future directions.

@article{Ramalingam2008SystemicCF,
  title={Systemic chemotherapy for advanced non-small cell lung cancer: recent advances and future directions.},
  author={Suresh S Ramalingam and Chandra Prakash Belani},
  journal={The oncologist},
  year={2008},
  volume={13 Suppl 1},
  pages={5-13}
}
Systemic therapy improves the survival and quality of life of patients with advanced stage non-small cell lung cancer (NSCLC). Several new therapeutic options have emerged for advanced NSCLC, incorporating novel cytotoxic agents (taxanes, gemcitabine, pemetrexed) and molecular-targeted agents (erlotinib, bevacizumab). Efforts to improve the outcome of first-line therapy for advanced and metastatic NSCLC have primarily focused on the addition of targeted agents to platinum-based two-drug… CONTINUE READING